Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium is the major intracellular cation, essential for maintaining cell membrane potential, nerve impulse transmission, muscle contraction, and acid-base balance. Dextrose provides caloric supplementation. Sodium chloride provides sodium and chloride ions for electrolyte balance.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. Adult dose is determined by fluid, electrolyte, and caloric requirements. Typically, 1000-3000 mL per day at a rate of 125-150 mL/hour, providing 0.22% KCl (2 mEq/L), 10% dextrose, and 0.2% NaCl (34 mEq/L Na+). Adjust based on serum potassium and glucose monitoring.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable as potassium chloride is an electrolyte; elimination follows first-order kinetics with a distribution half-life of ~8-10 minutes; plasma levels depend on infusion rate and renal function.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% as potassium and chloride ions, with potassium excretion primarily via distal tubular secretion and reabsorption; minimal fecal or biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte